The Information : SpaceX’s Starlink Revenue Per User Fell 18% As Customers Quadr

SpaceX’s Starlink Revenue Per User Fell 18% As Customers Quadrupled

The Takeaway
  • SpaceX says Starlink’s ARPU fell 18% to $81 between 2023 and 2025
  • SpaceX expects that figure to keep falling
  • Starlink’s individual subscriber business is bigger and growing faster than enterprise

SpaceX’s Starlink satellite internet service quadrupled its individual subscribers between 2023 and 2025—but the average revenue each subscriber brought in fell 18% to $81 a month in that period, a draft version of SpaceX’s initial public offering prospectus shows.

The decline in Starlink’s ARPU reflects the service’s introduction of cheaper plans and expansion outside North America, where average prices tend to be lower. SpaceX says in the prospectus that it expects that figure to keep falling in the next few years, as it continues its efforts to expand Starlink globally.

The newly revealed figures from SpaceX’s IPO paperwork show the economic impact of SpaceX’s efforts to transform Starlink from a niche offering for ultraremote users into a competitor to traditional internet service providers in the U.S., as well as a bigger presence in countries where users have less money to spend. That shift underpins SpaceX’s ambition to maintain growth for its main revenue stream, as it continues development work on its Starship rocket.

However, that shift also means Starlink is a significantly different business than some investors and analysts thought. In a 2024 report, Morgan Stanley put Starlink’s revenue per user at more than $170 per month. Starlink’s average revenue per user was $99 a month in 2023 and $91 in 2024.

Despite the declining ARPU, an increase in overall subscribers meant Starlink’s revenue nearly tripled to $11.4 billion in 2025 from $3.9 billion in 2023. Starlink accounted for about 60% of SpaceX’s overall $18.7 billion in revenue last year.

A spokesperson for SpaceX did not respond to a request for comment on the figures.

The economics of Starlink’s business are sure to be in the spotlight over the next few weeks, as SpaceX prepares to go public at a valuation expected to be well above $1 trillion.

When SpaceX first launched Starlink, it started by winning over consumers in well-heeled countries who were willing to shell out more than $100 per month for satellite broadband in locations like remote cabins, RVs and boats. But as SpaceX has cut prices and expanded the service to more countries over the past couple of years, the amount of money the company brings in from each Starlink user has fallen significantly.

SpaceX now offers plans for as little as $50 per month in the U.S., down from $120 in 2023. Plans are cheaper in other places like parts of Europe and Africa.

Amazon’s planned launch of its Leo satellite internet service later this year will put more pricing pressure on Starlink. In the meantime, SpaceX has taken other steps to reach more customers beyond price cuts, including giving away free internet access terminals in some regions. It usually sells terminals for hundreds of dollars each.

SpaceX even ran a Super Bowl ad for Starlink this year, the first for any company led by Elon Musk, who has said he hates advertising. SpaceX’s draft prospectus credits marketing efforts with growing the service, touting “increasing Starlink brand awareness” as a top “driver of our performance.”

In the investor document, SpaceX divides the customer base for Starlink broadband into two segments. One is individual subscribers, including both household consumers and business customers that don’t have bespoke deals managed by the Starlink sales team. The other segment is enterprise customers, including large entities such as governments, airlines and shipping companies that have customized deals with SpaceX.

The individual subscriber segment is the bigger and faster-growing business. At the end of 2025, Starlink had 8.9 million individual subscribers, up from 4.4 million in 2024 and 2.3 million in 2023. The 4.5 million subscribers added in 2025 increased Starlink revenue by about $2.4 billion, while enterprise grew $1.4 billion over the same period of time.

In 2025, more than 60% of Starlink’s revenue came from individual subscribers, according to SpaceX. The company said in the document that it expects individual subscribers to “remain the primary driver” of Starlink growth.

The document does not include financial details for Starlink Mobile, a separate business that uses a different group of SpaceX satellites to serve as backup to traditional cell towers, beyond saying that it expects mobile “will become a significant new contributor” to revenue in the future.

SpaceX’s initial deal with T-Mobile, its exclusive partner in the U.S., is worth approximately $100 million over multiple years tied to service milestones, making it a tiny slice of Starlink revenue.

SpaceX needs to figure out how to make money from Starlink Mobile because it’s spending nearly $20 billion in cash and stock to acquire spectrum rights to operate Starlink Mobile from EchoStar in a deal due to close in 2027.

TechCrunch : At his OpenAI trial, Musk relitigates an old friendship

At his OpenAI trial, Musk relitigates an old friendship

Among the most interesting parts of Elon Musk’s testimony Tuesday in his lawsuit against OpenAI wasn’t the charity he claims was stolen from him (we all knew that was coming). It was about an old friend.

Musk testified that one of his core motivations for co-founding OpenAI was a falling-out with Google’s Larry Page over AI safety — specifically, a conversation in which Musk raised the prospect of AI wiping out humanity and Page shrugged it off as “fine,” so long as AI itself survived. Page called Musk a “speciest” for being “pro human.” Musk called the attitude “insane.”

That’s mostly notable given how close the two once were. Fortune included them on its 2016 list of secretly best-friend business leaders; Musk was so comfortable with Page that he regularly crashed at his Palo Alto home. Page once told Charlie Rose that he’d rather give his money to Musk than to charity.

The friendship didn’t survive OpenAI. When Musk recruited Google AI star Ilya Sutskever to help launch the company in 2015, Page felt personally betrayed and cut off contact.

It’s a story Musk has told before — including to author Walter Isaacson for his bestselling biography of Musk — but Tuesday was the first time he said it under oath. Page hasn’t commented, and it’s worth remembering everything that Musk said was in service of a lawsuit. Still, as recently as 2023 he told tech podcaster Lex Fridman he wanted to patch things up: “We were friends for a very long time.”

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • OI -20.2%, RCKY -20.2%, CAR -14.8%, HOOD -11.1%, SOFI -8.2%, GEHC -7.3%, TER -6.8%, CTSH -6%, ENPH -5.9% (also announces development of IQ Solid-State Transformer for AI data centers), MX -5.1%, BKNG -4.8%, RBBN -4.2% (also names new CFO), NBR -3.8%, GSK -3.3%, CDNA -3.2% (also to acquire Naveris), HLN -3%, CMRE -3%, DB -2.9%, PRTC -2.5%, HUM -2.5%, MKL -2.3%, ETR -2.1%, JKS -2.1%, ATEN -2%, LRN -1.9%, RNR -1.8%, LYG -1.7%, OPK -1.6%, GEF -1.6%, GRMN -1.5%, IR -1.4%, RUSHA -1.3%, BXMT -1.3%, UNM -1.2%, VALE -1.2%, TW -1.2%
Other news:
  • OPTX -10.7% (prices offering of 2,857,142 shares of common stock at $7.00 per share)
  • NTLA -7.7% (prices offering of 16.7 mln shares of common stock at $10.75 per share)
  • CDNA -3.2% (files mixed securities shelf offering)
  • BF.A -2.7% (terminates merger discussions with Pernod Ricard)
  • VEON -1.7% (VEON and Kyivstar (KYIV) exceed $1 bln Ukraine investment commitment ahead of schedule)
  • VNO -1% (to purchase a 49% interest in Park Avenue Plaza)
Analyst comments:
  • STNE -2% (downgraded to Neutral from Buy at Goldman)
  • MELI -0.8% (downgraded to Neutral from Buy at UBS)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • SIMO +31.4%, BE +20.3%, NXPI +19.4%, STX +17.7%, COCO +16.9%, RSI +16.7%, VRNS +15.7%, FVRR +12.9%, FICO +12.4%, EXLS +11.8%, NEO +11%, GNRC +10.5%, AVTR +9.4%, LMND +8%, ETSY +7.9%, UMC +7.3%, ORN +7.2%, IEX +7.1%, PEB +6.3%, PRCH +5.9%, EXTR +5.9%, V +5.7% (also authorizes new $20 bln share repurchase program), LII +5.5%, SMG +5.4%, VIRT +5.3%, VLTO +5.2%, UBS +5%, TEVA +5%, GD +4.9%, UCTT +4.8% (also CFO to retire), WERN +4.7%, OSW +4.7%, ADP +4.7%, LAD +4.6%, SBUX +4.4%, ESI +4.4%, VMC +4.3%, IONS +4.2%, TRMK +4%, DK +4%, EAT +3.8%, PSN +3.7%, CLVT +3.6%, CHEF +3.5%, ARI +3.3%, YUMC +3.3%, MDLZ +3.2%, BIP +3.2%, SLGN +3.1%, MTRN +3.1%, VRSK +3%, CSTM +2.8%, AER +2.8%, SLDE +2.5% (also authorizes new $100 mln share repurchase program), PSX +2.3%, FFIV +2.1%, ASX +2.1%, EVR +2%, TMUS +1.9%, CZR +1.9%, BG +1.9%, BIIB +1.9%, EXE +1.5%, RNST +1.5% (also increases buyback authorization by $100 mln; also increases dividend), PAG +1.5%, BXP +1.4%, YUM +1.3%, STAG +1%, LSTR +1%
Other news:
  • TEVA +5% (announce a definitive agreement for Teva to acquire Emalex, including its lead asset, ecopipam)
  • TWO +3.5% (amends merger agreement with CrossCountry Mortgage)
  • ORKA +3.3% (prices offering of 9.66 mln shares of common stock at $72.50 per share)
  • KYIV +3% (VEON and Kyivstar (KYIV) exceed $1 bln Ukraine investment commitment ahead of schedule)
  • WDS +2.2% (reports Q1 operations, maintains FY26 guidance)
  • RJET +2% (names new CEO; reaffirms guidance)
  • CPT +2% (files mixed securities shelf offering)
  • DOCN +1.7% (unveils AI-native cloud built for the inference era)
  • RDY +1.6% (Health Canada announces compliance for RDY's generic version of NVO's Ozempic)
  • PTCT +1.4% (topline results from PIVOT-HD study of Votoplam)
  • ASB +1.2% (authorizes new $100 mln share repurchase program)
  • MESO +1.1% (achieves patient recruitment target in pivotal Phase 3 Trial for Chronic Low Back Pain)
Analyst comments:
  • NOK +4.6% (upgraded to Buy from Neutral at Arete)
  • VSCO +3.4% (upgraded to Buy from Neutral at BofA Securities)
  • CNC +2.7% (upgraded to Buy from Underperform at BofA Securities; upgraded to Overweight from Neutral at Cantor Fitzgerald)
  • MOH +2.6% (upgraded to Buy from Underperform at BofA Securities)
  • TMUS +2% (upgraded to Outperform from Perform at Oppenheimer)

>>> Garmin beats by $0.24, beats on revs; reaffirms FY26 EPS guidance, revs guid

Garmin beats by $0.24, beats on revs; reaffirms FY26 EPS guidance, revs guidance
  • Reports Q1 (Mar) earnings of $2.08 per share, excluding non-recurring items, $0.24 better than the FactSet Consensus of $1.84; revenues rose 14.0% year/year to $1.75 bln vs the $1.72 bln FactSet Consensus.
  • Gross and operating margins expanded to 59.4% and 24.6% respectively, compared to the prior year quarter.
  • Co reaffirms guidance for FY26, sees EPS of $9.35, excluding non-recurring items, vs. $9.40 FactSet Consensus; sees FY26 revs of $7.9 bln vs. $7.99 bln FactSet Consensus.

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Armstrong World Industries (AWI) upgraded to Outperform from In Line at Evercore ISI, tgt $200
    • Celestica (CLS) upgraded to Buy from Hold at TD Securities, tgt $430
    • Centene (CNC) upgraded to Buy from Underperform at BofA Securities, tgt $60
    • Centene (CNC) upgraded to Overweight from Neutral at Cantor Fitzgerald, tgt $60
    • Crane (CR) upgraded to Buy from Hold at Stifel, tgt $215
    • Elevance Health (ELV) upgraded to Buy from Neutral at BofA Securities, tgt $435
    • Franklin Resources (BEN) upgraded to Equal Weight from Underweight at Barclays, tgt $31
    • MaxLinear (MXL) upgraded to Buy from Hold at Loop Capital, tgt $75
    • Molina Healthcare (MOH) upgraded to Buy from Underperform at BofA Securities, tgt $250
    • NeoGenomics (NEO) upgraded to Outperform from Market Perform at Leerink Partners; tgt $25
    • Nokia (NOK) upgraded to Buy from Neutral at Arete
    • Procore Technologies (PCOR) upgraded to Outperform from Market Perform at Citizens, tgt $71
    • Qiagen (QGEN) upgraded to Outperform from Neutral at Robert W. Baird, tgt $43
    • Radian Group (RDN) upgraded to Buy from Underperform at BofA Securities, tgt $43
    • Spotify (SPOT) upgraded to Buy from Accumulate at IndeRes, tgt $570
    • Spotify (SPOT) upgraded to Buy from Neutral at Rosenblatt; tgt $500
    • Tamboran Resources (TBN) upgraded to Outperform from Sector Perform at RBC Capital, tgt $55
    • Telecom Argentina (TEO) upgraded to Overweight from Neutral at JPMorgan, tgt $16
    • T-Mobile (TMUS) upgraded to Outperform from Perform at Oppenheimer, tgt $260
    • Victoria's Secret (VSCO) upgraded to Buy from Neutral at BofA Securities, tgt $68
    • Zeta Global (ZETA) upgraded to Overweight from Sector Weight at KeyBanc, tgt $22
  • Downgrades:
    • Brown-Forman (BF.B) downgraded to Underweight from Neutral at JPMorgan, tgt $23
    • Clearwater Paper (CLW) downgraded to Hold from Buy at TD Cowen; tgt $17
    • MercadoLibre (MELI) downgraded to Neutral from Buy at UBS, tgt $2,050
    • Purple Innovation (PRPL) downgraded to Sector Weight from Overweight at KeyBanc
    • Qualys (QLYS) downgraded to Market Perform from Outperform at William Blair
    • Rapid7 (RPD) downgraded to Market Perform from Outperform at William Blair
    • StoneCo (STNE) downgraded to Neutral from Buy at Goldman, tgt $14
    • Sysco (SYY) downgraded to Hold from Buy at Deutsche Bank, tgt $84
    • Tenable (TENB) downgraded to Market Perform from Outperform at William Blair
    • Universal Health (UHS) downgraded to Mkt Perform from Outperform at Raymond James
  • Others:
    • Aktis Oncology (AKTS) initiated with an Outperform at William Blair
    • Alibaba (BABA) initiated with an Outperform at BNP Paribas, tgt $209
    • Corbus Pharmaceuticals (CRBP) initiated with a Buy at Guggenheim, tgt $45
    • Klaviyo (KVYO) resumed with an Overweight at Morgan Stanley, tgt $29
    • Legence (LGN) initiated with a Buy at Loop Capital, tgt $96
    • Wave Life Sciences (WVE) assumed with a Buy at Truist, tgt $15

>>> Early premarket gappers

Early premarket gappers
  • Gapping up:
    • SIMO +24.9%, BE +19.7%, STX +17.8%, NXPI +17.6%, RSI +15.5%, VRNS +15.2%, FICO +12.9%, GNRC +11.1%, EXLS +11%, NEO +10.8%, FVRR +9.6%, PRCH +8.8%, AKR +8.5%, CSTM +8.3%, AVTR +7.8%, ORN +7.3%, CLVT +7.2%, ASX +6.4%, PEB +5.6%, UBS +5.2%, V +4.8%, VNDA +4.7%, SBUX +4.6%, ESI +4.5%, VLTO +4.3%, TRMK +4%, YUMC +4%, ARI +3.3%, UCTT +3.2%, TWO +3.1%, WDS +3.1%, PPG +3%, ROG +2.8%, DOCN +2.5%, LSTR +2.5%, RJET +2%, BIIB +2%, BG +1.9%, LMND +1.8%, TMUS +1.7%, CZR +1.6%, ORKA +1.5%, ACGL +1.5%, EXE +1.5%, MDLZ +1.5%, ESS +1.5%, MIR +1.4%, ASH +1.4%, OKE +1.3%, ASB +1.2%, MESO +1.1%, NAVI +1.1%, STAG +1%, LAD +1%, SWK +1%
  • Gapping down:
    • OI -20.2%, RCKY -19.9%, HOOD -10.7%, OPTX -10.5%, ENPH -9.3%, TER -5.6%, CDNA -5.4%, BKNG -4.8%, MX -4.6%, LRN -4.5%, HUM -4.4%, RUSHA -3.9%, BF.A -3.8%, RBBN -3.5%, JKHY -3.1%, NBR -2.8%, FE -2.8%, DB -2.8%, HLN -2.7%, PRTC -2.5%, MKL -2.3%, WERN -2.3%, GSK -2.2%, ATEN -2%, NOG -1.9%, ATKR -1.8%, EQR -1.8%, VALE -1.7%, PCAR -1.6%, APAM -1.6%, GEF -1.6%, CSGP -1.4%, LYG -1.3%, UNM -1.2%, OMC -1.1%, VNO -1%, AZN -1%